logo

Ramsgate Consulting

 
HomeMedicalDentalVisionLifePrescriptionsNutritional supplementsCustomer serviceCompany profileOther sites of interest  
[clip art]


Study: Seniors' Drug Prices Tripled

By JANELLE CARTER, Associated Press Writer
Mon Jun 24, 5:22 PM ET

WASHINGTON (AP) - The prices of the 50 most prescribed drugs for older Americans rose, on average, at almost triple the overall rate of inflation last year, a study says.

The liberal consumer advocacy group Families USA released the report in advance of the House debate scheduled to start Wednesday on a Republican-backed bill that would spend $310 billion over 10 years to provide seniors with a prescription drug benefit.

"Prescription drugs for seniors are becoming increasingly unaffordable," said Ron Pollack, Family USA's executive director. "Some of the most popular drugs increased at intervals of eight and nine times."

Jeff Trewitt, a spokesman for the Pharmaceutical Research and Manufacturers of America, the industry's trade group, said the report was misleading.

"The report completely ignores the fact that retail prices vary widely among pharmacies in a single community," Trewitt said. "Retail prices of the same medicine can vary by more than 100 percent within a few city blocks. It is essential we correct the notion that all elderly patients pay the same price for the same drug."

Besides, Trewitt said, "the pharmaceutical price tag is almost always far cheaper than the cost of surgery and hospitalization."

According to the report, the drugs Demadex, a diuretic, and Premarin, an estrogen replacement drug, both rose 17.8 percent, almost seven times the rate of inflation last year.

Plavix, an anti-clotting drug, rose 16.8 percent, more than six times the inflation rate, while the cholesterol-lowering Lipitor rose five times the rate of inflation.

The report used data from Pennsylvania's state-run prescription drug program for the elderly, those 65 and older, to develop the list of the 50 top-selling drugs. Price histories were then obtained from a database published by Medi-Span/Facts and Comparisons.

The rate of inflation used in the report, 2.7 percent, is for January 2001 to January 2002 and excludes highly volatile energy and food prices.

"There is no reasonable basis for these alarming price increases, which continue to make prescription drugs unaffordable for too many seniors," Pollack said.

The study found that 10 of the 50 most-prescribed drugs for seniors are generics. The average annual price for those drugs was $375. Nine of those drugs did not increase in price at all.

The other 40 most prescribed drugs are brand-name medications with an average annual price of $1,106. Only three of the brand-name drugs did not increase in price last year.

Pollack said the study showed that "generics are not only cheaper, but they are generally rising in price at much slower rates than brand-name drugs."

The rapid rise in prices means that even if Congress passes a prescription drug benefit, it may eventually be too costly even for the government, Pollack said.
 

back to top

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Mail
Send us an E-mail
 

HEADLINE NEWS

 

(Click on underlined headings for complete story)

 

ANTHEM BLUE CROSS ANNOUNCES AVAILABILITY OF LIPITOR GENERIC: On November 30, 2011, Anthem Blue Cross added a new generic drug called Atorvastatin to tier 1.

Seniors Get A Break on Medicare Part B Premiums: Part B premiums for Medicare beneficiaries will rise less than originally anticipated next year, the Department of Health and Human Services announced Thursday.

Obama Administration cuts California Medi-Cal Reimbursements: The Obama administration approved significant Medi-Cal cuts Thursday that health care providers and patient advocates warn will reduce access for California's most vulnerable residents.

TRUSTEES: MEDICARE HOSPITAL FUND EXTENDED 12 YEARS:  But officials cautioned Thursday that the gain will depend on achieving significant savings in health care in coming years.

American's Coming Health Care Oligopoly:  Can you say "insuragopoly"? How about "hospigopoly"? Then you better learn, because they describe how the health care system is changing under President Obama's health care reform legislation.

Health Overhaul May Mean Longer ER Waits, Overcrowding:  Rand Corp. researcher Dr. Arthur L. Kellermann predicts this from the new law: "More people will have coverage and will be less afraid to go to the emergency department if they're sick or hurt and have nowhere else to go.... We just don't have other places in the system for these folks to go."

5 PAINFUL HEALTH-CARE LESSONS FROM MASSACHUSETTS:  The best guide to how President Obama's historic health-care legislation will reshape the nation's medical marketplace and fiscal future is the pioneering model in Massachusetts. The Bay State's reform program started in late 2006, and it shares virtually all the major features of the new federal plan.

Dartmouth Study on Health Care Costs:  In selling the health care overhaul to Congress, the Obama administration cited a once obscure research group at Dartmouth College to claim that it could not only cut billions in wasteful health care spending but make people healthier by doing so.

OBAMACARE'S FUZZY MATH -- HIGH RISK POOLS WILL COST 8 TIMES WHAT IS BUDGETED:  One feature of the health overhaul that the President is touting as an immediate benefit is the expansion of so-called "high risk pools" for people who want to buy insurance but can't because of their poor health. The problem is that there's no way that $5 billion, which is what's been budgeted, will cover the cost of covering 2 million people. The real cost will be more like $40 billion.

RESCISSIONS:  MUCH ADO ABOUT NOTHING:  How many times have you heard President Obama say, "Health insurers won’t be able to drop your coverage just because you get sick?" Or Kathleen Sebelius? Or the Democratic leadership in Congress? Or the mainstream news media? You would think that the private health insurance industry was being revolutionized.

OBAMACARE’S HIDDEN TIME BOMB:  One of the quirks of ObamaCare is that most of its key provisions don't go into effect until 2014. But in any 2,300-page law, there are bound to be provisions that have immediate and unintended consequences. One such provision is Section 2718, entitled "Bringing Down The Cost Of Health Care Coverage."

DOCTOR SHORTAGE?  28 STATES MAY EXPAND NURSES' ROLE:   A nurse may soon be your doctor. With a looming shortage of primary care doctors, 28 states are considering expanding the authority of nurse practitioners.

Once-a-Week Workout Keeps Elderly Strong: One workout a week can mean the difference between frailty and freedom.

FDA OKs Device to Treat Back Pain: The government on Tuesday approved sales of a device that could radically change surgery for certain back pain sufferers.

 

 

Archives - Alpha Archives by Date